Abstract
TherapeuticsJanuary 1, 2001Review: Maximum androgen blockade does not confer additional survival benefit to androgen suppression in prostate cancerAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/ACPJC-2001-134-1-023 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack Citations ShareFacebookTwitterLinkedInRedditEmail Source CitationProstate Cancer Trialists' Collaborative Group. Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials. Lancet. 2000 Apr 29;355:1491-8. https://pubmed.ncbi.nlm.nih.gov/10801170 (All 2001 articles were reviewed for relevancy, and abstracts were last revised in 2006.)References1 Schmitt B, Bennett C, Seidenfeld J, Samson D, Wilt T. Maximal androgen blockade for advanced prostate cancer. Cochrane Database Syst Rev. 2000;(2):CD001526. [PMID: 10796804] Google Scholar2 Rosendahl I, Kiebert GM, Curran D, et al. Quality-adjusted survival (Q-TwiST) analysis of EORTC trial 30853: comparing goserelin acetate and flutamide with bilateral orchiectomy in patients with metastatic prostate cancer. European Organization for Research and Treatment of Cancer. Prostate. 1999;1:100-9. [PMID: 9973095] Google Scholar3 Moinpour CM, Savage MJ, Troxel A, et al. Quality of life in advanced prostate cancer: results of a randomized therapeutic trial. J Natl Cancer Inst. 1998;90:1537-44. [PMID: 790546] Google Scholar Author, Article, and Disclosure InformationAffiliations: PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails January 1, 2001Volume 134, Issue 1Page: 23KeywordsAdverse reactionsAge groupsAndrogensComputersDatabasesDeath ratesDrugsInformation retrievalInformation storage and retrievalProstate cancerQuality of lifeToxicity ePublished: 9 March 2020 Issue Published: January 1, 2001 Copyright & PermissionsCopyright © 2001 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
